Study on the Safety, Efficacy of Home RF Cosmetic Instrument in the Treatment of Facial or Periorbital Wrinkles（F-MFR300-RD-003）

Inclusion Criteria: * (1) Adults aged 18 and above, male or female; * (2) Fitzpatrick's wrinkles and elasticity scores around the face and eyes were 2-7 points (on-site assessment); * (3) To avoid sun exposure during the test; * (4) Be able to read Chinese and accurately understand, and sign the informed consent of the test; * (5) can cooperate with and participate in the test return visit time, and timely reflect their own health status or any changes in drugs, adverse reaction symptoms; * (6) Urine pregnancy reaction is negative (women of childbearing age). Exclusion Criteria: * (1) Abnormal vital signs (blood pressure, pulse, body temperature), except for minor abnormalities that are not clinically significant as determined by the doctor; * (2) There is a pacemaker or internal defibrillator in the body, or any other active electrical implant anywhere in the body; * (3) The treatment area has permanent implants, such as metal plates and screws (e.g. dentures, metal teeth), silicone implants or injected chemicals; * (4) There is or has been a history of skin cancer, or any other type of cancer, or malignant pre-nevus; * (5) serious comorbidities, such as heart disease, epilepsy, high blood pressure and liver or kidney disease; * (6) Plan to become pregnant or breastfeed during the study period, or less than 6 months after delivery; * (7) Have a history of bleeding and clotting, or long-term use of anticoagulation and antiplatelet drugs (aspirin ≤81mg daily is not excluded); * (8) Suffering from autoimmune diseases; * (9) have an immunosuppressive disease such as AIDS, or an impaired immune system caused by the use of immunosuppressive drugs (investigators' judgment); * (10) Subjects with a history of heat-stimulated disease, such as recurrent herpes simplex in the treatment area, should only be treated after a preprevention regimen; * (11) Poor control of diseases related to the endocrine system as determined by the investigator, such as diabetes or thyroid dysfunction; * (12) Any active condition in the treatment area identified by the investigator, such as ulcers, eczema, or other skin lesions; * (13) A history of skin diseases, such as keloid, abnormal wound healing, psoriasis, etc.; * (14) Any invasive or non-invasive treatment (such as hair removal, light rejuvenation, microneedles or chemical exfoliation, etc.) in the treated area within 3 months prior to treatment; * (15) Received RF microneedle therapy, injection of fillers or botulinum toxin within 6 months prior to treatment; * (16) Receive semi-permanent fillers (poly-l-lactic acid, calci-hydroxyphospholite, etc.) within 24 months before treatment; * (17) Have undergone facial medical or cosmetic surgery (e.g. eyelid/ eyebrow surgery, periorbital or perioral soft tissue enhancement, permanent fillers, permanent makeup, tattoos, etc.); * (18) Use of drugs that may trigger photosensitization during the study period (such as quinolones, aspirin, hyd rochlorothiazide or furosemide); * (19) Use of any medications that affect skin characteristics (e.g., vitamin A, steroids, thyroid medications, etc.) in the past 6 months; * (20) Participate in a clinical trial of another drug or device in which the last treatment of the investigational drug/device occurred 3 months before the start of treatment in the study; * (21) Plan to change previously used skin care products during the study period; * (22) Other conditions deemed unsuitable for inclusion by the researcher.